Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Surgalign Hldg Inc (SRGA)

Surgalign Hldg Inc (SRGA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Surgalign Announces Global Settlement Agreement with Resolve Surgical Technologies and RTI Surgical, Inc. Globe Newswire - Wed Aug 10, 2022

Parties enter into new sole-source supply relationship, extended for two years...

SRGA : 0.1829 (-32.98%)
Surgalign Holdings, Inc. Announces Second Quarter 2022 Results and Reiterates Full Year 2022 Revenue Guidance Range Globe Newswire - Tue Aug 9, 2022

DEERFIELD, Ill., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the...

SRGA : 0.1829 (-32.98%)
Surgalign Names Paolo Amoruso Chief Legal Officer and Corporate Secretary Globe Newswire - Thu Aug 4, 2022

DEERFIELD, Ill., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the...

SRGA : 0.1829 (-32.98%)
Surgalign Reaches Settlement with the Securities and Exchange Commission on Matters Related to Prior Management Between 2015-2019 Globe Newswire - Wed Aug 3, 2022

DEERFIELD, Ill., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) reached a settlement with the U.S. Securities and Exchange...

SRGA : 0.1829 (-32.98%)
Surgalign Announces the Commercial Relaunch of its Next Generation CervAlign Anterior Cervical Plate System Optimized for Discectomy and Fusion Procedures Globe Newswire - Wed Jul 20, 2022

DEERFIELD, Ill., July 20, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the...

SRGA : 0.1829 (-32.98%)
Surgalign Announces Partnership with PRIA Healthcare to Improve Patient Healthcare Coverage Globe Newswire - Thu Jul 14, 2022

Program to aid in patient access to Surgalign’s Coflex® Interlaminar Stabilization® andSImmetry® SI Joint Fusion Systems DEERFIELD, Ill., July 14, 2022 ...

SRGA : 0.1829 (-32.98%)
Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Globe Newswire - Wed Jul 6, 2022

DEERFIELD, Ill., July 06, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the...

SRGA : 0.1829 (-32.98%)
Surgalign™ Announces Clinical Site Expansion in the Commercialization of its HOLO Portal™ Surgical Guidance System in Ohio Globe Newswire - Wed Jul 6, 2022

This marks the second medical facility to clinically use HOLO Portal, the world’s first artificial intelligence (AI)-driven, augmented reality (AR)...

SRGA : 0.1829 (-32.98%)
Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Globe Newswire - Fri Jun 3, 2022

DEERFIELD, Ill., June 03, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the...

SRGA : 0.1829 (-32.98%)
Surgalign Holdings, Inc. Announces 1-for-30 Reverse Stock Split Globe Newswire - Mon May 16, 2022

DEERFIELD, Ill., May 16, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the...

SRGA : 0.1829 (-32.98%)

Barchart Exclusives

Why This Dividend Stock Just Scored a Rare Upgrade Barchart - 1 hour ago
Bristol Myers Squibb, a global biopharma company, has received a rare upgrade from Jefferies due to its promising pipeline and strategic partnerships. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot